203 related articles for article (PubMed ID: 29579066)
1. Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing.
Gillio-Tos A; Fiano V; Grasso C; Trevisan M; Gori S; Mongia A; De Marco L; Ronco G;
PLoS One; 2018; 13(3):e0194619. PubMed ID: 29579066
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
Bryant D; Tristram A; Liloglou T; Hibbitts S; Fiander A; Powell N
J Clin Virol; 2014 Jan; 59(1):24-9. PubMed ID: 24268385
[TBL] [Abstract][Full Text] [Related]
3. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia.
Turan T; Kalantari M; Cuschieri K; Cubie HA; Skomedal H; Bernard HU
Virology; 2007 Apr; 361(1):185-93. PubMed ID: 17175003
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
5. Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus.
Brestovac B; Harnett GB; Smith DW; Frost F; Shellam GR
J Clin Virol; 2005 Jun; 33(2):116-22. PubMed ID: 15911426
[TBL] [Abstract][Full Text] [Related]
6. Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers.
Mori S; Nakao S; Kukimoto I; Kusumoto-Matsuo R; Kondo K; Kanda T
Cancer Sci; 2011 Jun; 102(6):1223-7. PubMed ID: 21388488
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens.
Husnjak K; Grce M; Magdić L; Pavelić K
J Virol Methods; 2000 Aug; 88(2):125-34. PubMed ID: 10960700
[TBL] [Abstract][Full Text] [Related]
8. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay.
Schmitt M; Dondog B; Waterboer T; Pawlita M; Tommasino M; Gheit T
J Clin Microbiol; 2010 Jan; 48(1):143-9. PubMed ID: 19864475
[TBL] [Abstract][Full Text] [Related]
9. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia.
Tate JE; Yang YC; Shen J; McLachlin CM; Sheets EE; Crum CP
Mol Cell Probes; 1996 Oct; 10(5):347-51. PubMed ID: 8910889
[TBL] [Abstract][Full Text] [Related]
10. Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers.
Szostek S; Klimek M; Zawilinska B; Rys J; Kope J; Daszkiewic E
Acta Biochim Pol; 2006; 53(3):603-7. PubMed ID: 17019439
[TBL] [Abstract][Full Text] [Related]
11. Relationship between hybrid capture II ratios and DNA amplification of E1, E6 and L1 genes used for the detection of human papillomavirus in samples with different cytological findings.
Lurchachaiwong W; Junyangdikul P; Payungporn S; Chansaenroj J; Sampatanukul P; Tresukosol D; Termrungruanglert W; Poovorawan Y
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):217-24. PubMed ID: 20232576
[TBL] [Abstract][Full Text] [Related]
12. High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma.
Farhadi A; Behzad-Behbahani A; Geramizadeh B; Sekawi Z; Rahsaz M; Sharifzadeh S
J Med Virol; 2014 Jul; 86(7):1134-44. PubMed ID: 24700118
[TBL] [Abstract][Full Text] [Related]
13. Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format.
Kornegay JR; Shepard AP; Hankins C; Franco E; Lapointe N; Richardson H; Coutleé F;
J Clin Microbiol; 2001 Oct; 39(10):3530-6. PubMed ID: 11574568
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
15. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.
Chen Z; Jing Y; Wen Q; Ding X; Zhang S; Wang T; Zhang Y; Zhang J
Virol J; 2016 Oct; 13(1):167. PubMed ID: 27717385
[TBL] [Abstract][Full Text] [Related]
16. A teat papillomatosis case in a Damascus goat (Shami goat) in Hatay province, Turkey: a new putative papillomavirus?
Dogan F; Dorttas SD; Bilge Dagalp S; Ataseven VS; Alkan F
Arch Virol; 2018 Jun; 163(6):1635-1642. PubMed ID: 29502149
[TBL] [Abstract][Full Text] [Related]
17. Comparison of L1 consensus primers with E6 type specific primers for detection of human papillomaviruses in paraffin sections of cervical neoplasia.
Park JS; Namkoong SE; Han SK; Nha DJ; Lee HY; Kim SJ
J Korean Med Sci; 1993 Feb; 8(1):60-7. PubMed ID: 8393681
[TBL] [Abstract][Full Text] [Related]
18. Direct sequencing of consensus primer generated PCR fragments of human papillomaviruses.
Rady PL; Chin R; Arany I; Hughes TK; Tyring SK
J Virol Methods; 1993 Aug; 43(3):335-50. PubMed ID: 8408447
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women.
Bryant D; Hibbitts S; Almonte M; Tristram A; Fiander A; Powell N
J Clin Virol; 2015 May; 66():66-71. PubMed ID: 25866341
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
